Xenetic Biosciences, Inc. (XBIO) Financials
XBIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 12.0 million | 1.1 million |
2023-06-30 | 12.7 million | 871315 |
2023-03-31 | 13.7 million | 856365 |
2022-12-31 | 14.7 million | 1.1 million |
XBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -949634 | 70266 |
2023-06-30 | -1.3 million | 69389 |
2023-03-31 | -1.1 million | 68852 |
2022-12-31 | -750907 | 118651 |
XBIO Net Income
No data available :(
XBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 9.8 million | - | - |
2023-06-30 | 10.7 million | - | - |
2023-03-31 | 12.0 million | - | - |
2022-12-31 | 13.1 million | - | - |
XBIO Shares Outstanding
XBIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.0 million | 737241 | - |
2023-06-30 | - | 903243 | 945950 | - |
2023-03-31 | - | 595276 | 925743 | - |
2022-12-31 | - | 1.2 million | 857167 | - |
XBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 611174 | - |
2023-06-30 | 651005 | - |
2023-03-31 | 605844 | - |
2022-12-31 | 486972 | - |
XBIO
Price: $4.30
52 week price:
Earnings Per Share: -2.71 USD
P/E Ratio: -1.31
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 27600
Ebitda: -8.4 millionMarket Capitalization: 6.8 million